Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      German Merck aims to role out child formula for schistosomiasis drug

      German Merck aims to role out child formula for schistosomiasis drug

      supriya kashyap kashyap19 April 2017 11:42 AM IST
      Merck KGaA said it is developing a children's formula of its drug to treat schistosomiasis, a parasitic worm disease that infects millions of poor...
      PMs push for generic drugs to shift focus to chemists, says pharma industry body

      PM's push for generic drugs to shift focus to chemists, says pharma industry body

      supriya kashyap kashyap19 April 2017 11:41 AM IST
      New Delhi : Patients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines as indicated by...
      J&J first quarter revenue misses estimates; new forecast includes Actelion

      J&J first quarter revenue misses estimates; new forecast includes Actelion

      supriya kashyap kashyap19 April 2017 11:41 AM IST
      Johnson & Johnson reported disappointing pharmaceutical and consumer product sales as revenue missed analyst estimates, sending its shares sharply...
      Jubilant Life raises Rs 100 cr by issue of commercial papers

      Jubilant Life raises Rs 100 cr by issue of commercial papers

      supriya kashyap kashyap19 April 2017 11:41 AM IST
      New Delhi : Drug firm Jubilant Life Sciences said it has raised Rs 100 crore through issuing commercial papers.The company has issued commercial...
      Sun Pharma Share Price Falls 3 Percent on 11 Observations from USFDA for Dadra Unit

      Sun Pharma Share Price Falls 3 Percent on 11 Observations from USFDA for Dadra Unit

      supriya kashyap kashyap19 April 2017 9:38 AM IST
      Sun Pharmaceutical Industries share price fell 3 percent. Investors turned cautious as sources told CNBC-TV18 that company's Dadra unit has received...
      USFDA inspects Baroda plant, no observations issued: Alembic

      USFDA inspects Baroda plant, no observations issued: Alembic

      supriya kashyap kashyap18 April 2017 11:18 AM IST
      New Delhi : Alembic Pharmaceuticals said no observations were issued by US health regulator USFDA after inspection of its Baroda facility.The...
      Unichem Labs gets USFDA nod for arthritis drug

      Unichem Labs gets USFDA nod for arthritis drug

      supriya kashyap kashyap18 April 2017 11:17 AM IST
      New Delhi : Drug firm Unichem Laboratories said it has received approval from the US health regulator for Piroxicam Capsules, used in treatment of...
      Finally, DRL’s Srikakulam API plant gets USFDA nod

      Finally, DRL’s Srikakulam API plant gets USFDA nod

      supriya kashyap kashyap18 April 2017 11:16 AM IST
      New Delhi : Drug firm Dr Reddy's Laboratories said the US health regulator has completed inspection of its Srikakulam facility without making any...
      OncoMeds lung cancer drug fails mid-stage study, shares tumble

      OncoMed's lung cancer drug fails mid-stage study, shares tumble

      supriya kashyap kashyap18 April 2017 9:18 AM IST
      OncoMed Pharmaceuticals Inc's shares were jolted for a second time in a week after the company said its experimental lung cancer drug failed a...
      Takeda enrols more Than 20,000 Children,Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate

      Takeda enrols more Than 20,000 Children,Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate

      supriya kashyap kashyap17 April 2017 11:48 AM IST
      Takeda Pharmaceutical Company Limited, announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16in its global,...
      US Healthtech Startup AkosMD Coming to India

      US Healthtech Startup AkosMD Coming to India

      supriya kashyap kashyap17 April 2017 11:48 AM IST
      AkosMD was started in the US to facilitate affordable and faster primary healthcare, a basic right which often is too expensive and takes long to...
      Sanofi to boost volumes, exports as price control hits margins

      Sanofi to boost volumes, exports as price control hits margins

      supriya kashyap kashyap17 April 2017 11:42 AM IST
      Mumbai : With price controls continuing to crimp margins, Sanofi India expects a muted growth in the domestic market in 2017 and therefore will be...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok